Assessing an expanse of ALS targets 

The target list to treat amyotrophic lateral sclerosis continues to grow, and the majority of newly proposed targets from a BioCentury summary suggest restoring neurotransmission may slow the progressive degeneration of nerve cells characterized by the disease.

An analysis from BioCentury’s Distillery and Translation in Brief series from 2018 to present revealed 18 proposed targets to treat ALS. It is a snippet from 11 papers across eight journals, rather than a comprehensive analysis...